Grayson Fan, Loman Leo, Nonnenmacher Toby, Pople Diane, Pollard Jack, Patel Bharat, Williams David, Hounsome Luke, Hopkins Katie L, Robotham Julie V, Ledda Alice
Advanced Analytics, Analysis & Intelligence Assessment, Chief Data Officer Group, UK Health Security Agency, London, UK.
Chief Data Officer Group Private Office, Chief Data Officer Group, UK Health Security Agency, London, UK.
Microb Genom. 2025 Mar;11(3). doi: 10.1099/mgen.0.001361.
Plasmids are well-known vehicles of antimicrobial resistance (AMR) gene dissemination. Through conjugation, plasmid-encoded AMR genes are spread among neighbouring bacteria, irrespective of their strain or even their species. This process is very concerning from a public health perspective, as plasmid-borne AMR gene outbreaks are often not confined to single species or strains and are therefore more difficult to fully uncover. At the moment, the impact of plasmid conjugation on within-patient plasmid diversity is not well understood. In this work, we will tackle the role of conjugation on within-patient plasmid diversity using a dataset of carbapenemase-producing . The dataset of 256 sequences originates from bacterial isolates cultured from 115 English patients over 30 months. Each patient has more than one sequence, with at least one sequence carrying an OXA-48 gene, a well-known plasmid-borne carbapenemase-encoding gene. If more than one sequence carries the OXA-48 gene, they are carried in different bacterial hosts. Using a hybrid -on-reference assembly pipeline, we were able to reconstruct the full OXA-48 plasmid from short read sequencing data for 232 of the 256 sequences. Of the 115 patients, 83 (72%) patients had an identical OXA-48 plasmid in two or more sequences. Only two patients carried very different (200 SNPs) alleles of the OXA-48 plasmid, probably from separate acquisitions. Our study shows that when more than one bacterial host carrying an OXA-48 plasmid is found in a patient, it is most likely that the same plasmid has been shared via conjugation. The event of separate acquisition of different plasmids in different bacterial hosts is highly unlikely in our dataset.
质粒是众所周知的抗微生物耐药性(AMR)基因传播载体。通过接合作用,质粒编码的AMR基因在邻近细菌之间传播,无论它们的菌株甚至物种如何。从公共卫生角度来看,这个过程非常令人担忧,因为质粒携带的AMR基因爆发往往不限于单一物种或菌株,因此更难完全发现。目前,质粒接合对患者体内质粒多样性的影响尚不清楚。在这项工作中,我们将使用产碳青霉烯酶的数据集来研究接合作用对患者体内质粒多样性的作用。256个序列的数据集来自于30个月内从115名英国患者培养的细菌分离株。每个患者有多个序列,至少有一个序列携带OXA - 48基因,这是一种众所周知的质粒携带的碳青霉烯酶编码基因。如果有多个序列携带OXA - 48基因,它们存在于不同的细菌宿主中。使用混合的基于参考的组装流程,我们能够从256个序列中的232个短读长测序数据重建完整的OXA - 48质粒。在115名患者中,83名(72%)患者在两个或更多序列中具有相同的OXA - 48质粒。只有两名患者携带非常不同(200个单核苷酸多态性)的OXA - 48质粒等位基因,可能来自单独的获得。我们的研究表明,当在患者体内发现多个携带OXA - 48质粒的细菌宿主时,很可能是通过接合作用共享了相同的质粒。在我们的数据集中,不同细菌宿主中单独获得不同质粒的情况极不可能发生。